Correction to: Nature Reviews Clinical Oncologyhttps://doi.org/10.1038/s41571-023-00849-9, published online 8 January 2024. In the version of the article initially published, there was an error in the second paragraph of the introduction, where “mouse erbB2” has been corrected to “human HER2” in the sentence now reading “Among these, a mouse mAb targeting human HER2 demonstrated remarkable preclinical activity…” in the HTML and PDF versions of article.
Correction to: Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives / A. Marra, S.C.. - In: NATURE REVIEWS. CLINICAL ONCOLOGY. - ISSN 1759-4774. - 21:9(2024), pp. 701-701. [10.1038/s41571-024-00933-8]
Correction to: Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
A. MarraPrimo
;
2024
Abstract
Correction to: Nature Reviews Clinical Oncologyhttps://doi.org/10.1038/s41571-023-00849-9, published online 8 January 2024. In the version of the article initially published, there was an error in the second paragraph of the introduction, where “mouse erbB2” has been corrected to “human HER2” in the sentence now reading “Among these, a mouse mAb targeting human HER2 demonstrated remarkable preclinical activity…” in the HTML and PDF versions of article.
| File | Dimensione | Formato | |
|---|---|---|---|
|
unpaywall-bitstream--2074816263.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Licenza:
Nessuna licenza
Dimensione
514.27 kB
Formato
Adobe PDF
|
514.27 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
